Evidence map›Paper›PMID 22837047›Full record

ArticleCellular and molecular neurobiology2012

Crosstalk between JNK and NF-κB in the KDO2-mediated production of TNFα in HAPI cells.

Xuexing Zheng, Wenwen Zheng, Shue Liu, Harshil M Patel, Xianzhu Xia, Hongsheng Ouyang, Roy C Levitt, Keith A Candiotti, Shuanglin Hao

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Phosphorylated CCAAT/Enhancer Binding Protein β Contributes to Rat HIV-Related Neuropathic Pain:The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  3. Kdo2 -lipid A: structural diversity and impact on immunopharmacology.Biological reviews of the Cambridge Philosophical Society · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Xuexing ZhengDepartment of Anesthesiology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Wenwen Zheng
Shue Liu
Harshil M Patel
Xianzhu Xia
Hongsheng Ouyang
Roy C Levitt
Keith A Candiotti
Shuanglin Hao
University of Miami · USJilin University · CN

Funding

HIV and NRTI's-induced painful pathogenic mechanisms and gene therapyR01NS066792 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2010 to 2014
$1.6M
Pathogenesis and Therapy of HIV-Related Neuropathic PainR21DA025527 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2009 to 2010
$423k
Gene therapy of HIV-neuropathic pain with morphine toleranceR03DA026734 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HAO, SHUANGLIN · 2009 to 2010
$309k
NIDA NIH HHS DA025527NIDA NIH HHS DA026734NIDA NIH HHS R03 DA026734NIDA NIH HHS R21 DA025527NINDS NIH HHS NS066792NINDS NIH HHS R01 NS066792
6 · The paper itself

Abstract

Both nuclear factor kappa B (NF-κB) and mitogen-activated protein kinases mediate production of proinflammatory cytokines in many types of cells. c-Jun N-terminal kinases (JNK) is a key regulator of many cellular events including cell inflammation and/or programmed cell death (apoptosis). In addition to mediating immune and inflammatory responses, NF-κB transcription factors control cell survival. It is reported that activation of NF-κB antagonizes apoptosis or programmed cell death by numerous triggers. It has been reported that NF-κB activation results in rapid inactivation of JNK in tumor necrosis factor alpha (TNFα)-treated murine embryonic fibroblasts. It is not clear about the relationship of JNK and NF-κB in the microglial cells induced by TLR4 activity. In the present study, we investigated the relationship of JNK and NF-κB in the highly aggressively proliferating immortalized microglial cell line treated with KDO2 (a TLR4 agonist). KDO2 treatment significantly induced the phosphorylation of JNK and NF-κB, and released TNFα. Knockdown of TLR4 with TLR4 siRNA significantly reduced phosphorylation of JNK (pJNK), phosphorylation of NF-κB, and release of TNFα. Inhibition of JNK reduced the release of TNFα, but not phosphorylation of NF-κB. Unexpectedly, inhibition of NF-κB enhanced pJNK and the release of TNFα. These results showed that TNFα induced by KDO2 was JNK-dependent, and that NF-κB negatively modulated both pJNK and TNFα in the cultured microglial cell line. The current study may provide a new insight in the modulation of TNFα in the microglial cell line.

Indexed as

AnimalsCell LineCell Line, TransformedDose-Response Relationship, DrugLipopolysaccharidesMAP Kinase Kinase 4MicrogliaNF-kappa BPhosphorylationRatsReceptor Cross-TalkToll-Like Receptor 4Tumor Necrosis Factor-alphaKdo2-lipid ALipopolysaccharidesMAP Kinase Kinase 4NF-kappa BTlr4 protein, ratToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID22837047
PMCPMC11498372
OpenAlexW2095438871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.